Blueprint MedicinesBPMC 
$93.14-2.04%24h
-2.04%24h
Global rank2552
Market cap$5.64B
Change 7d-0.63%
YTD Performance2.87%
SP500 benchmarkUnderperform
P/E-11.13
P/S22.62
Revenue$249.38M
Earnings-$506.98M
Dividend yield-
Main Sector
Healthcare
EPS for Blueprint Medicines (BPMC)
Blueprint Medicines has an EPS of $-8.37. In 2022, the company made an earnings per share (EPS) of $-9.35. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for BPMC
-
Value:-
EPS history for Blueprint Medicines from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$8.37 | -10.48% |
| 2022 | -$9.35 | -15.08% |
| 2021 | -$11.01 | -296.96% |
| 2020 | $5.59 | - |
View the highest EPS stocks
